1473002

Noroxymorphone hydrochloride

United States Pharmacopeia (USP) Reference Standard

• 別名: (5α)-4,5-Epoxy-3,14-dihydroxymorphinan-6-one monohydrochloride
• 実験式（ヒル表記法）: C₁₆H₁₇NO₄ · HCl
• CAS番号: 52446-24-9
• 分子量: 323.77
• MDL number: MFCD08272693
• UNSPSC Code: 41116107
• NACRES: NA.24

特性

• 製品名: Noroxymorphone hydrochloride, United States Pharmacopeia (USP) Reference Standard
• SMILES string: Cl.N1[C@H]2[C@]3([C@@]4([C@@H](Oc5c4c(ccc5O)C2)C(=O)CC3)CC1)O
• InChI: 1S/C16H17NO4.ClH/c18-9-2-1-8-7-11-16(20)4-3-10(19)14-15(16,5-6-17-11)12(8)13(9)21-14;/h1-2,11,14,17-18,20H,3-7H2;1H/t11-,14+,15+,16-;/m1./s1
• InChI key: QMFVIJMHPXUVOL-RCGDHTHDSA-N
• grade: pharmaceutical primary standard
• API family: noroxymorphone
• manufacturer/tradename: USP
• drug control: USDEA Schedule I; regulated under CDSA - not available from Sigma-Aldrich Canada
• application(s): pharmaceutical (small molecule)
• format: neat

詳細

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Application

Noroxymorphone hydrochloride USP reference standard, intended for use in specified quality tests and assays as specified in the USP compendia.

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including MSDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia.

Other Notes

Sales restrictions may apply.

安全性情報

• pictograms: GHS07
• signalword: Warning
• hcodes: H336
• pcodes: P261 - P271 - P304 + P340 + P312 - P403 + P233 - P405 - P501
• Hazard Classifications: STOT SE 3
• target_organs: Central nervous system
• 保管分類: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable